Metropolis Healthcare Limited
Metropolis Healthcare Limited (METROPOLIS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider
metropolisindia.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Stock price
₹591.90
Market cap
12,286 Cr
Stock P/E
64.0
P/B
8.03
Dividend yield
0.2%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 309 Cr | 291 Cr | 331 Cr | 313 Cr | 350 Cr | 323 Cr | 345 Cr | 386 Cr | 429 Cr | 406 Cr | 425 Cr | 450 Cr |
| Operating expenses (approx.) | 234 Cr | 226 Cr | 251 Cr | 235 Cr | 260 Cr | 251 Cr | 283 Cr | 296 Cr | 321 Cr | 311 Cr | 317 Cr | 339 Cr |
| EBITDA | 75 Cr | 65 Cr | 80 Cr | 79 Cr | 90 Cr | 72 Cr | 62 Cr | 90 Cr | 108 Cr | 95 Cr | 108 Cr | 111 Cr |
| OPM % | 24.2% | 22.3% | 24.2% | 25.2% | 25.7% | 22.3% | 18.0% | 23.2% | 25.2% | 23.4% | 25.4% | 24.7% |
| Other income | 1 Cr | 2 Cr | 3 Cr | 2 Cr | 3 Cr | 3 Cr | 7 Cr | 8 Cr | 0.89 Cr | 9 Cr | 8 Cr | 5 Cr |
| Interest | 6 Cr | 5 Cr | 6 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 6 Cr | 6 Cr | 8 Cr | 6 Cr |
| Depreciation | 22 Cr | 25 Cr | 26 Cr | 26 Cr | 27 Cr | 28 Cr | 29 Cr | 31 Cr | 32 Cr | 32 Cr | 39 Cr | 32 Cr |
| Profit before tax | 48 Cr | 37 Cr | 51 Cr | 51 Cr | 61 Cr | 42 Cr | 36 Cr | 61 Cr | 71 Cr | 57 Cr | 70 Cr | 78 Cr |
| Tax % | 25.9% | 26.0% | 27.7% | 25.4% | 23.9% | 25.7% | 18.9% | 26.1% | 25.5% | 26.4% | 27.0% | 26.8% |
| Net profit | 36 Cr | 27 Cr | 37 Cr | 38 Cr | 47 Cr | 31 Cr | 29 Cr | 45 Cr | 53 Cr | 42 Cr | 51 Cr | 57 Cr |
| EPS (₹) | ₹6.92 | ₹5.30 | ₹7.11 | ₹7.41 | ₹9.08 | ₹6.11 | ₹5.69 | ₹8.70 | ₹10.17 | ₹7.99 | ₹2.46 | ₹2.73 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 761 Cr | 856 Cr | 998 Cr | 1,228 Cr | 1,148 Cr | 1,208 Cr | 1,331 Cr | 1,646 Cr | Sign in for TTM |
| Operating expenses (approx.) | 561 Cr | 624 Cr | 712 Cr | 886 Cr | 860 Cr | 925 Cr | 1,028 Cr | 1,245 Cr | Sign in for TTM |
| EBITDA | 200 Cr | 233 Cr | 286 Cr | 343 Cr | 288 Cr | 283 Cr | 303 Cr | 401 Cr | Sign in for TTM |
| OPM % | 26.3% | 27.2% | 28.7% | 27.9% | 25.1% | 23.4% | 22.8% | 24.4% | Sign in for TTM |
| Other income | 8 Cr | 9 Cr | 12 Cr | 18 Cr | 15 Cr | 9 Cr | 15 Cr | 26 Cr | Sign in for TTM |
| Interest | 0.53 Cr | 8 Cr | 8 Cr | 20 Cr | 27 Cr | 23 Cr | 19 Cr | 25 Cr | Sign in for TTM |
| Depreciation | 20 Cr | 39 Cr | 46 Cr | 63 Cr | 89 Cr | 94 Cr | 109 Cr | 134 Cr | Sign in for TTM |
| Profit before tax | 187 Cr | 169 Cr | 244 Cr | 293 Cr | 188 Cr | 175 Cr | 191 Cr | 259 Cr | Sign in for TTM |
| Tax % | 33.7% | 24.4% | 25.0% | 26.8% | 23.5% | 26.5% | 23.8% | 26.2% | Sign in for TTM |
| Net profit | 124 Cr | 128 Cr | 183 Cr | 215 Cr | 143 Cr | 128 Cr | 146 Cr | 191 Cr | Sign in for TTM |
| EPS (₹) | ₹24.06 | ₹25.36 | ₹35.97 | ₹41.87 | ₹27.91 | ₹24.95 | ₹28.29 | ₹9.19 | Sign in for TTM |
| Dividend payout % | — | — | — | 19.1% | 28.6% | 16.0% | 12.7% | 10.8% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 10 Cr | 41 Cr |
| Reserves | 409 Cr | 513 Cr | 698 Cr | 876 Cr | 978 Cr | 1,086 Cr | 1,321 Cr | 1,472 Cr |
| Borrowings | 18 Cr | — | — | 259 Cr | 79 Cr | — | 14 Cr | 19 Cr |
| Other liabilities | 115 Cr | 227 Cr | 296 Cr | 384 Cr | 432 Cr | 456 Cr | 519 Cr | 595 Cr |
| Total liabilities | 553 Cr | 752 Cr | 1,004 Cr | 1,530 Cr | 1,502 Cr | 1,555 Cr | 1,867 Cr | 2,138 Cr |
| Fixed assets (net) | 117 Cr | 121 Cr | 115 Cr | 139 Cr | 137 Cr | 156 Cr | 190 Cr | 215 Cr |
| CWIP | 6 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Investments | 33 Cr | 14 Cr | 10 Cr | 16 Cr | 15 Cr | 55 Cr | 71 Cr | 337 Cr |
| Loans & advances | 15 Cr | 11 Cr | 4 Cr | 0.05 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Inventories | 26 Cr | 24 Cr | 41 Cr | 51 Cr | 45 Cr | 39 Cr | 48 Cr | 45 Cr |
| Trade receivables | 137 Cr | 128 Cr | 123 Cr | 135 Cr | 122 Cr | 126 Cr | 148 Cr | 170 Cr |
| Cash & bank | 51 Cr | 107 Cr | 387 Cr | 66 Cr | 69 Cr | 63 Cr | 39 Cr | 55 Cr |
| Other assets | 167 Cr | 346 Cr | 325 Cr | 1,123 Cr | 1,114 Cr | 1,117 Cr | 1,371 Cr | 1,315 Cr |
| Total assets | 553 Cr | 752 Cr | 1,004 Cr | 1,530 Cr | 1,502 Cr | 1,555 Cr | 1,867 Cr | 2,138 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 253 Cr | 247 Cr | 264 Cr | 263 Cr | 351 Cr |
| Cash from investing | — | — | — | -735 Cr | 47 Cr | -89 Cr | -201 Cr | -223 Cr |
| Cash from financing | — | — | — | 163 Cr | -292 Cr | -181 Cr | -87 Cr | -115 Cr |
| Net cash flow | — | — | — | -321 Cr | 3 Cr | -6 Cr | -24 Cr | 15 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 223 Cr | 194 Cr | 200 Cr | 194 Cr | 307 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 43.5% | 33.1% | 35.6% | 35.3% | 20.0% | 17.9% | 15.5% | 18.4% |
| ROE % | 27.9% | 23.8% | 25.9% | 24.2% | 14.4% | 11.6% | 10.9% | 12.5% |
| Debtor days | 65 | 55 | 45 | 40 | 39 | 38 | 40 | 38 |
| Inventory days | 55 | 44 | 59 | 67 | 64 | 58 | 65 | 51 |
| Days payable | 90 | 152 | 160 | 136 | 135 | 150 | 171 | 145 |
| Cash conversion cycle | 30 | -54 | -56 | -29 | -32 | -53 | -65 | -56 |
| Debt / equity | 0.04 | — | 0.00 | 0.29 | 0.08 | — | 0.01 | 0.01 |
| Current ratio | 2.45 | 2.34 | 2.98 | 1.30 | 1.14 | 1.28 | 1.18 | 1.40 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | -0.22 | -0.08 | -0.09 |
Compare with peers
Loading peers…